Asset Acquisition - Schedule of Total Consideration, Assets and the Liabilities (Details) - AlmataBio Transaction - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
Mar. 28, 2024 |
Mar. 27, 2024 |
Mar. 31, 2024 |
|
| Asset Acquisition, Contingent Consideration [Line Items] | |||
| Stock consideration | $ 12,272 | ||
| Milestone payment due upon close of private placement investment | $ 7,500 | 7,500 | |
| Milestone payment due upon first patient dosed in a Phase 2 trial | 5,000 | ||
| Transaction costs | 2,402 | ||
| Total GAAP Purchase Price at Close | 27,174 | ||
| Acquired IPR&D | 27,538 | ||
| Cash | 356 | ||
| Accrued expenses and other current liabilities | (720) | ||
| Total net assets acquired and liabilities assumed | $ 27,174 | ||
| Common stock shares issued (in shares) | 171,605 | ||
| Shares issuable in common stock (in shares) | 2,412 | ||
| Convertible preferred stock, shares issued upon conversion (in shares) | 2,412,000 | ||
| Closing stock price (in dollars per share) | $ 4.75 |
| X | ||||||||||
- Definition Asset Acquisition, Acquired In Process Research and Development No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Assets Acquired and Liabilities Assumed, Net No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Cash and Equivalents No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Equity Interest Issued Or Issuable, Number Of Common Stock Shares No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Equity Interest Issued Or Issuable, Number Of Convertible Preferred Stock Shares No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Liabilities, Accrued Expenses And Other, Current No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Share Price No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of contingent consideration recognized as part of consideration transferred in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of transaction cost incurred as part of consideration transferred in asset acquisition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares issued for each share of convertible preferred stock that is converted. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|